Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
124001
Image_2_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.jpeg
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124002
Image_3_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.jpeg
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124003
DataSheet_4_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.zip
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124004
DataSheet_1_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.pdf
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124005
Image_1_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.jpeg
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124006
DataSheet_3_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.zip
Published 2022“…The treatment of BRAF<sup>V600E</sup> and MEK inhibitor, PLX4720 and PD0325901, decreased the expression of miR-222-3p in B-CPAP but not in TPC-1. …”
-
124007
Quantitative Comparison of Constitutive Promoters in Human ES cells
Published 2010“…During embryoid body (EB) differentiation, promoter activities of all five promoters decreased. Although the EF1α promoter was downregulated in approximately 50% of the cells, it was the most stable promoter during differentiation. …”
-
124008
Secondary structure model for the X(−) RNAs
Published 2011“…The absence of colour indicates that the reactivity of the given nucleotide could not be determined because of the presence of a band in the control lane. The reactivity of nt 83–100 towards CMCT has not been determined. …”
-
124009
Gene expression analysis associated with tissue-specific promoters in Musa spp.
Published 2022“…It was determined that five genes were specific or expressed to a greater extent in some tissues than others. …”
-
124010
An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma
Published 2016“…This analysis represents an update to a previous paper in which we evaluated the exposure–response relationships for lung cancer and mesothelioma in chrysotile-exposed cohorts. …”
-
124011
Interactions between the intestinal microbiome and host genes in regulating vibriosis resistance in Cynoglossus semilaevis
Published 2025“…<p dir="ltr">Chinese tongue sole (Cynoglossus semilaevis) is now a commercially important and widely farmed flatfish species in China. …”
-
124012
-
124013
Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: development, characterization, and <i>in vivo</i> investigation using BALB/c mice model
Published 2021“…The optimized ethosomal a conventional cream was evaluated for cytotoxicity using HaCat cell lines and <i>in vivo</i> on BALB/c mice model. …”
-
124014
Antioxidant Actions of Thymoquinone, Silymarin, and Curcumin on Experimental Aortic Ischemia-Reperfusion Model in Wistar Albino Rats
Published 2022“…Conclusion: Silymarin and thymoquinone administration decreases oxidative stress in experimental aortic ischemia-reperfusion injury. …”
-
124015
-
124016
Supplementary Material for: Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease
Published 2020“…IFN-γ production of circulating MAIT cells in response to both MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased in IBD patients, which was partially associated with reduced activation of nuclear factor of activated T cells 1 (NFAT1) transcription factor, a main regulator of IFN-γ production. …”
-
124017
-
124018
Syneresis and chemical characteristics of fermented rice extract with probiotic bacteria and waxy maize starch
Published 2017“…<div><p>Abstract The objective of this work was to elaborate fermented extracts using rice bran and broken rice grains (proportion 8:92) with probiotic bacteria and different concentrations of waxy maize starch (WMS) in order to obtain products with low level of syneresis and desirable physical-chemical characteristics, and to evaluate the content of phenolic compounds, antioxidant capacity and chemical composition of the extract selected and flavored with strawberry aroma and strawberry syrup. A randomized design was used with five treatments (0, 4, 8, 12 and 16 g 100 g–1 of WMS) and four replications. …”
-
124019
‘Alecrim Pimenta’ nanoformulated essential oil (Lippia sidoides) as additive in consortium silages
Published 2023“…BRS Ponta Negra) silage intercropped with Paiaguás grass (Urochloa brizantha cv. BRS Paiaguás). A 4 x 3 factorial design was adopted, with four additives applied to the silages (control treatment; nanoformulated "Alecrim Pimenta" essential oil (OEN); 62% nanoformulated thymol; and 100% pure nanoformulated thymol), associated with three silo period times (15, 30 and 45 days), with five replications per treatment, totaling 60 mini silos. …”
-
124020